Pancreatic Cancer Research

ResearcherThe First People's Hospital of NeijiangNo recent work listed

Liang Lai

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5102360670. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

  1. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8. Co-author DOI 10.1016/j.biopha.2018.12.121↗
  2. Expression of miRNA-143 in Pancreatic Cancer and Its Clinical Significance. Last author DOI 10.1089/cbr.2018.2500↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fei Xie · 2 shared papers, 2018–2019 · strength 0.19
  2. Tinggang Mou · 2 shared papers, 2018–2019 · strength 0.19
  3. Qin Yang · 1 shared paper, 2019 · strength 0.11
  4. Jie Wang · 1 shared paper, 2019 · strength 0.11
  5. Hao Hua · 1 shared paper, 2019 · strength 0.11
  6. Bo Xu · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.